OTC Short Interest drops significantly from 729,105 to 475,882 -34.80% as of 03/31
|
4
|
Resverlogix Corp.
|
Apr 20, 2022 01:15PM
|
asked a couple weeks back or so about my Hepa concern - no feed back.
|
4
|
Resverlogix Corp.
|
Apr 21, 2022 10:59AM
|
Re: asked a couple weeks back or so about my Hepa concern - no feed back.
|
3
|
Resverlogix Corp.
|
Apr 21, 2022 12:32PM
|
short # ?
|
2
|
Resverlogix Corp.
|
Apr 22, 2022 12:38PM
|
Re: short # ?
|
2
|
Resverlogix Corp.
|
Apr 22, 2022 02:08PM
|
Re: New Apabetalone Fabry Disease Publication
|
5
|
Resverlogix Corp.
|
Apr 27, 2022 01:10PM
|
Re: New Apabetalone Fabry Disease Publication
|
8
|
Resverlogix Corp.
|
Apr 28, 2022 01:06PM
|
Re: New Apabetalone Fabry Disease Publication
|
6
|
Resverlogix Corp.
|
Apr 29, 2022 01:28PM
|
Re: Market Woes
|
5
|
Resverlogix Corp.
|
Apr 30, 2022 10:54AM
|
looking ahead,backwards or sideways?
|
2
|
Resverlogix Corp.
|
May 02, 2022 12:22PM
|
Re: looking ahead,backwards or sideways?
|
4
|
Resverlogix Corp.
|
May 02, 2022 01:09PM
|
Re: A couple of things
|
2
|
Resverlogix Corp.
|
May 02, 2022 01:57PM
|
Re: A couple of things
|
9
|
Resverlogix Corp.
|
May 03, 2022 12:34PM
|
hepa's up its max 10% with double avg vol..
|
3
|
Resverlogix Corp.
|
May 04, 2022 10:48PM
|
keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
4
|
Resverlogix Corp.
|
May 05, 2022 04:26PM
|
Re: keep doing PPs at .48/shr with a .50 warrant good till 2025 donny
|
5
|
Resverlogix Corp.
|
May 05, 2022 05:10PM
|
" Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
4
|
Resverlogix Corp.
|
May 09, 2022 07:47AM
|
Re: " Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
4
|
Resverlogix Corp.
|
May 09, 2022 09:13AM
|
think its time
|
3
|
Resverlogix Corp.
|
May 09, 2022 09:56AM
|
Trying to understand this NR?
|
4
|
Resverlogix Corp.
|
May 09, 2022 10:31AM
|